Capricor Therapeutics Inc. (4LN2)
Market Open
12 Jun, 13:26
XFRA 
€
21. 00
-0.35
-1.6393%
€
- Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
- Eps
€ 21.35
Previous Close Want to track 4LN2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
4LN2 Earnings Reports FAQ
What is the earnings per share (EPS) for 4LN2?
EPS data for 4LN2 is currently not available, as Capricor Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Capricor Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Capricor Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Capricor Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 4LN2 at this time, as Capricor Therapeutics Inc has no recent EPS data to calculate it.
